Net Income (Annual) Chart

View Net Income (Annual) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Net Income (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2025 -38.89M
December 31, 2024 -82.22M
December 31, 2023 -59.34M
December 31, 2022 -105.74M
December 31, 2021 7.728M
December 31, 2020 -18.14M
December 31, 2019 -22.74M
December 31, 2018 -116.25M
December 31, 2017 -68.59M
December 31, 2016 -85.75M
December 31, 2015 -148.78M
December 31, 2014 -56.36M
December 31, 2013 -166.56M
December 31, 2012 -180.11M
Date Value
December 31, 2011 -69.42M
December 31, 2010 -249.52M
December 31, 2009 -59.30M
December 31, 2008 -20.28M
December 31, 2007 -38.17M
December 31, 2006 -26.72M
December 31, 2005 -20.56M
December 31, 2004 4.646M
December 31, 2003 -19.22M
December 31, 2002 -34.73M
December 31, 2001 -5.066M
December 31, 2000 -2.594M
December 31, 1999 -10.13M
December 31, 1998 -1.607M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. 478.60M
Alkermes Plc 241.66M
Cellectis SA -67.80M
Akari Therapeutics Plc -17.34M
Liquidia Corp. -68.92M